Intelligence / Healthtech / New Clinical Trials
ClinicalLIVEUpdated 18 Nov 2026
New Clinical Trials
Clinical trials companies registered in the last 30 days, worldwide, with the sponsor, phase and countries.
Sources: ClinicalTrials.gov · Rebuilt weekly · Trials first posted in the window whose lead sponsor is a company, worldwide. Device and diagnostic studies usually have no phase.
Trials
777
in the 30 days to 2026-11-18
Added in 30 days
777
to 18 Nov 2026
Top country
United States
192 · 25% of the list
Phase covered
8
distinct values
Snapshot · 18 Nov 2026
Explore all 777 Growth
By month
777
Signals
What the register says this week, and why it matters if you sell into it.
- United States leads with 192 of 777, then China (171).
- 777 added in the 30 days to 18 Nov 2026.
- 174 of the listed studies are device, diagnostic or digital-health studies (no drug phase).
- A new trial needs sites, patients, data capture, monitoring and regulatory partners for years.
PostedSponsorStudyPhaseStatus
13 Nov 2026Revision SkincareScalp Serum Paired With HydraFacial HydraScalp Keravive™ Treatment in Patients With Self-Perceived Hair ThinningNot applicableNot Yet Recruiting13 Nov 2026Shanghai Henlius BiotechAustralia, ChinaA Phase I Study of HLX109 in Healthy ParticipantsPhase 1Not Yet Recruiting13 Nov 2026SkylineDxProspective, Multi-Center Observational Registry of Melanoma CP-GEP and Clinical OutcomesNot Yet Recruiting13 Nov 2026Suzhou Siran Biotechnology Co.,Ltd.ChinaSA030 Injection in Healthy ParticipantsPhase 1Not Yet Recruiting13 Nov 2026Suzhou Zenith Vascular SciTech LimitedChinaSingle-Arm Trial of Carotid Stenting for Carotid Stenosis (Timing Trial)Not applicableNot Yet Recruiting13 Nov 2026UCB Biopharma SRLA Study to Evaluate the Placental Transfer of Dapirolizumab Pegol to the Infant(s) From Pregnant Study Participants With Active Systemic Lupus Erythematosus Who Are Administered Dapirolizumab PegolPhase 1Not Yet Recruiting13 Nov 2026ViiV HealthcareMass Balance and Absolute Bioavailability of [14C]-VH4011499Phase 1Not Yet Recruiting13 Nov 2026Zhuhai Hengqin ImStem Biotechnology Co., Ltd.ChinaA Study of IMS001 in Patients With Multiple SclerosisPhase 1Recruiting12 Nov 20264bases Italia SrlItalyStudy to Compare Traditional and Emerging Methods for Structural Variant Analysis in Prenatal, Postnatal, and Hematologic SamplesRecruiting12 Nov 2026AbbVieA Study to Assess Targeted Therapies for Treatment of Adults With Moderate to Severe PsoriasisPhase 2Not Yet Recruiting12 Nov 2026AbbVieA Study to Evaluate the Safety and Efficacy (How Well the Study Treatment Works) of ABBV-2294 in Adult Participants With Systemic Sclerosis That Are Currently Receiving Local Standard of Care Treatment, and to Determine the Best Dose of ABBV-2294 to be Evaluated Further.Phase 2, Phase 3Not Yet Recruiting12 Nov 2026AbbVieM4 Receptor PET Radioligand Validation Study in Healthy AdultsEarly Phase 1Not Yet Recruiting12 Nov 2026Aether Tech S.L.SpainAutomated Versus Manual Oxygen Titration With the EMILY.AI Device in Hospitalized Patients With Acute Respiratory FailureNot applicableNot Yet Recruiting12 Nov 2026Aponia Laboratories, Inc.United States, GermanyEffect of S-Ibuprofen Gel on Pain in Acute Soft Tissue ContusionsPhase 3Recruiting12 Nov 2026AstraZenecaA Modular, Phase I/II Study to Evaluate CT204V-CD19 x CD20 in Participants With Relapsed or Refractory B-Cell Malignancies.Phase 1, Phase 2Not Yet Recruiting12 Nov 2026AstraZenecaChina, Hong Kong, MalaysiaA Phase III Study to Assess the Effect of FDC Laroprovstat/Rosuvastatin Compared With Laroprovstat, Rosuvastatin, and Placebo on LDL-C in LLT-naïve PatientsPhase 3Not Yet Recruiting12 Nov 2026AstraZenecaChanges in Symptom and Quality of Life in Patients With Uncontrolled Asthma Treated With Budesonide/Glycopyrronium/Formoterol Fumarate Metered Dose Inhaler (BGF MDI)Not Yet Recruiting12 Nov 2026Beijing VDJBio Co., LTD.ChinaPhase I Trial of Subcutaneous VDJ010 In Healthy Subjects and Patients With Ulcerative ColitisPhase 1Recruiting12 Nov 2026Beijing Youcare Kechuang Pharmaceutical Technology Co., Ltd.ChinaClinical Study of YKYY013 Injection in HBeAg-negative Chronic Hepatitis B Virus-infected Patients Treated With Nucleos(t)Ide AnaloguesPhase 2Not Yet Recruiting12 Nov 2026BeOne MedicinesA Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Food Effect of BON-107 in Healthy ParticipantsPhase 1Not Yet Recruiting12 Nov 2026Colgate PalmoliveUnited StatesClinical Evaluation of an Oil-Balancing Facial Sunscreen With Topical TretinoinPhase 4Enrolling By Invitation12 Nov 2026Croma-Pharma GmbHAustriaRevitalis - Midface (Cheek Area)Not applicableRecruiting12 Nov 2026CSPC-NBP Pharmaceutical Co., Ltd.ChinaA Multicenter, Randomized, Blinded, Placebo- and Active-Controlled Phase II Study to Evaluate the Efficacy and Safety of SYH9061 in Adult Patients With Idiopathic Pulmonary FibrosisPhase 2Not Yet Recruiting12 Nov 2026Daewon Pharmaceutical Co., Ltd.South KoreaClinical Trial to Evaluate the Safety and Efficacy of DW4421 in Patients With Erosive Reflux DiseasePhase 3Completed12 Nov 2026ENTire Medical Ltd.United StatesPediatric Adeno-Tonsillar Hypertrophy Treatment Post-Approval StudyNot applicableNot Yet Recruiting12 Nov 2026Gedeon Richter Plc.United StatesSafety, Tolerability and Efficacy of RGH-202 in Social Anxiety Disorder (STAGE)Phase 2Not Yet Recruiting12 Nov 2026HALEONSingaporeA Retrospective Study to Assess Patient-Reported Treatment Experience With Over-the-Counter Analgesic ProductsNot Yet Recruiting12 Nov 2026Hangzhou DAC Biotechnology Co., Ltd.ChinaA Study of DXC016 in Patients With Advanced Solid Tumors.Phase 1Not Yet Recruiting12 Nov 2026HK inno.N CorporationSouth KoreaEfficacy and Safety of Kabalin Cap.(Pregabalin) in Patients With Neuropathic PainRecruiting12 Nov 2026HK inno.N CorporationSouth KoreaBlood Pressure Control and Safety of Ex-one or Ex-one Plus in Essential HypertensionRecruiting12 Nov 2026IMMUNOe Research CentersUnited StatesExploring the Extended Efficacy and Initial Use of RUCONEST® in Managing Neurological Symptoms Linked to Infectious PathogensPhase 4Recruiting12 Nov 2026InSilico Medicine Hong Kong LimitedUnited Arab EmiratesA Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM9528Phase 1Recruiting12 Nov 2026Institut de Recherches Internationales Servier (I.R.I.S.)A Study to Assess Safety, Tolerability, Pharmacokinetics, and Efficacy of S247240 in Adult Male Participants With Fragile X SyndromePhase 2Not Yet Recruiting12 Nov 2026Jiangsu Hansoh Pharmaceutical Co., Ltd.ChinaA Phase I Study to Evaluate the Effect of Food on the Pharmacokinetics of HS-10382 Tablets in Healthy ParticipantsPhase 1Not Yet Recruiting12 Nov 2026Liaoning Chengda Biotechnology CO., LTDChinaImmunogenicity and Safety of Freeze-Dried Human Rabies Vaccine (Vero Cell) in Patients Infected With Human Immunodeficiency Virus (HIV)Phase 4Recruiting12 Nov 2026Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, GermanyGermanyStudy of Multiple Ascending Doses (MAD) of M5542 in Participants With Moderate and Severe EczemaPhase 1Not Yet Recruiting12 Nov 2026MSK Doctors & Associates LtdUnited KingdomElectrical Muscle Stimulation (EMS) Versus Standard Physiotherapy for Quadriceps Recovery Following Total Knee ReplacementNot applicableRecruiting12 Nov 2026Neurocrine BiosciencesUnited StatesStudy of NBIB-223 Gene Therapy in Friedreich's Ataxia (FACET)Phase 1Not Yet Recruiting12 Nov 2026Novelty Nobility, Inc.ChinaA Study of NN2802, an Anti-c-Kit Antibody, in Healthy Participants and in Adults With Chronic Spontaneous Urticaria (CSU)Phase 1, Phase 2Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, BrazilA Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or BothPhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Argentina, AustraliaAMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, China, JapanA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes Treated With Diet and ExercisePhase 3Not Yet Recruiting12 Nov 2026Novo Nordisk A/SUnited States, Brazil, ChinaA Research Study Investigating How Well Zenagamtide Lowers Blood Sugar and Body Weight Compared to Placebo in People With Type 2 Diabetes and Chronic Kidney Disease Treated With Once Daily Basal Insulin Alone or in Combination With Metformin, SGLT2i, or BothPhase 3Not Yet Recruiting12 Nov 2026Olly, PBCUnited StatesThe Pediatric Sleep StudyNot applicableNot Yet Recruiting12 Nov 2026Oruka Therapeutics, Inc.United States, CanadaAn Open-label Study With Maintenance Dosing of ORKA-002 in Participants With Moderate-to-Severe Plaque PsoriasisPhase 2Enrolling By Invitation12 Nov 2026Otsuka Pharmaceutical Development & Commercialization, Inc.VIS954 for Treating Inflammatory Skin ProblemsPhase 2Not Yet Recruiting12 Nov 2026Perfect Care DistributionRomaniaHalova Vaginal Ovules Versus Vaginal Estriol for Genitourinary Symptoms in Postmenopausal WomenNot applicableCompleted12 Nov 2026PfizerA Study to Learn How Different Amounts of the Study Medicine Called PF-08166744 Are Tolerated and Act in Healthy Adults.Phase 1Not Yet Recruiting12 Nov 2026PfizerUnited StatesA Study to Learn About the Study Medicine Called Prifetrastat in People With Renal ImpairmentPhase 1Not Yet Recruiting12 Nov 2026PfizerThe Purpose of This Study is to Learn About the Safety and Effectiveness of Berobenatide in Women With Urine Leakage and With Obesity or OverweightPhase 3Not Yet Recruiting// How AOS uses this